# Iambic Therapeutics Prices $150 Million Initial Public Offering at $16 Per Share

- URL: https://stocks.freetheai.org/news/iambic-therapeutics-prices-150-million-initial-public-offering-at-16-per-share-0e7611
- Published: 2026-10-15T08:18:25Z
- Category: ipo; sentiment: neutral; impact: medium
- Written by our AI from expert market sources across the web for FreeTheAI Stocks, built by Vibhek Soni
- How write-ups are made: https://stocks.freetheai.org/how-we-write
- Not financial advice: https://stocks.freetheai.org/disclaimer

Biotechnology firm Iambic Therapeutics (IAM) has set the price for its initial public offering at $16.00 per share. The company is offering 9.38 million shares of common stock, which is expected to raise $150 million in total gross proceeds before deducting discounts and expenses. All of the stock in this transaction is being sold directly by the business.

The funding gives the biotech company fresh capital to push forward its research pipeline. Management intends to direct the net proceeds toward developing three of its early-stage cancer drug candidates. In addition, underwriters have been given a 30-day option to buy up to an extra 1.41 million shares at the initial public offering price.

Trading in the common stock is scheduled to start on October 15, 2026, on the Nasdaq Global Select Market under the ticker symbol "IAM." The offering is slated to formally close on October 16, 2026, subject to customary closing conditions.

## Key points

- Iambic Therapeutics priced 9.38 million shares of common stock at $16.00 each in its initial public offering.
- The offering is expected to generate $150 million in gross proceeds, with all shares sold by the company.
- Proceeds from the deal will be used to advance three early-stage cancer drug programs.
- Shares are scheduled to begin trading on October 15, 2026, on the Nasdaq Global Select Market under ticker IAM.
- Underwriters have a 30-day option to purchase up to an additional 1.41 million shares.

## Questions and answers

### What is the IPO price for Iambic Therapeutics?

Iambic Therapeutics priced its initial public offering at $16.00 per share.

### When does Iambic Therapeutics stock start trading on Nasdaq?

The company's shares are scheduled to begin trading on October 15, 2026, under the ticker symbol IAM.

### How will Iambic Therapeutics use the funds from its IPO?

The company plans to use the proceeds from the offering to advance three early-stage cancer drug candidates.